Topical imiquimod

Journal of Dermatological Treatment

Volumn 12, Issue 1, 2001, Pages 37-40

  Pearson, G W ^a   Langley, R G B ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Cytokine; Human papilloma virus; Imiquimod Immune response modifier; Immunomodulator

Indexed keywords

CYTOKINE; IMIQUIMOD;

ARTICLE; CONDYLOMA; DIARRHEA; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; EROSION; ERYTHEMA; FATIGUE; FEVER; HEADACHE; HUMAN; MACROPHAGE; MOLLUSCUM CONTAGIOSUM; MONOCYTE; MYALGIA; PRIORITY JOURNAL; REPRODUCTIVE TOXICITY; SKIN IRRITATION; TREATMENT OUTCOME;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, TOPICAL; AMINOQUINOLINES; CONDYLOMATA ACUMINATA; HUMANS; OINTMENTS;

EID: 0035040445     PISSN: 09546634     EISSN: None     Source Type: Journal    
DOI: 10.1080/095466301750163572     Document Type: Article

References (18)

1. Effects of the immunomodulating agent R-837 on acute and latent herpes simplex virus type 2 infections
2. Posttherapy suppression of genital herpes simplex virus (HSV) recurrences and enhancement of HSV-specific T-cell memory by imiquimod in Guinea pigs
3. Imiquimod
4. Treatment of genital warts with an immune-response modifier (imiquimod)
5. Imiquimod, a novel immune response modifier induces migration of Langerhans cells
6. Percutaneous penetration of [14C] imiquimod from a single application of cream
7. Self-administered topical 5% imiquimod cream for external anogenital warts
8. New treatments for genital warts less than ideal
9. The cost effectiveness of patient-applied versus provider-administered intervention strategies for the treatment of external genital warts
10. Treatment of molluscum contagiosum in males with an analog of imiquimod 1% in cream: A placebo-controlled double-blind study
11. Topical imiquimod therapy for chronic giant molluscum contagiosum in a patient with advanced human immunodeficiency virus 1 disease
12. Multivariate risk score for recurrence of cutaneous basal cell carcinomas
13. Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream
14. Safety and efficacy of imiquimod 5% cream for the treatment of Bowen's disease
15. Modulation of TH1 and TH2 cytokine production with the immune response modifiers. R-848 and imiquimod
16. External genital warts: Report of the American Medical Association consensus conference
17. Imiquimod, a patient-applied immune response modifier for treatment of external genital warts